Alnylam Pharmaceuticals Inc. won expanded US approval for a heart drug that could be the biggest boon yet for the 23-year-old ...

NIKE (NYSE:NKE – Get Free Report) had its target price cut by BMO Capital Markets from $95.00 to $92.00 in a report released ...

United States Steel (NYSE:X – Get Free Report) had its price target boosted by BMO Capital Markets from $40.00 to $45.00 in a ...

Stocks are off to a shaky start in Trump's second term, but bullish strategists aren't losing hope. Here's where they're ...

WASHINGTON (Reuters) -U.S. retail sales rebounded marginally in February as consumers pulled back on discretionary spending, ...

Brian Belski, BMO Capital Markets chief investment strategist, joins CNBC's 'Squawk on the Street' to break down market ...

Recent declines in U.S. stocks are likely not large enough to make it onto the Federal Reserve’s radar, and officials probably welcome a modest correction in risk assets, BMO Capital Markets ...

According to BMO's analysis, Cenovus Energy, Spartan Delta, and Kelt Exploration saw the highest levels of total insider ...

A rebound in several megacaps pushed stocks away from session lows, while disappointing outlooks from bellwethers across ...

Short-sellers have profited off the AI trade's stumbling start to 2025 as investors begin to question the overall growth ...

BMO Capital Markets initiated coverage on Dyne Therapeutics (DYN, Financials) with an Outperform rating and a $50 price target, suggesting a strong upside from the company's current share price of ...

On Thursday, BMO Capital Markets sustained their Market Perform rating on Casey’s General Stores (NASDAQ:CASY), with a steady price target of $450.00. The convenience store chain, currently ...